News

The Anticancer Fund is now part of FORCE, a major European initiative supporting research on rare and hard-to-treat cancers. Alongside 13 non-profit partners from 11 countries, we’re working to bring better, evidence-based treatments to patients who urgently need them.

On International Clinical Trials Day, we’ve reached a milestone: more than 1.000 patients are participating in our 7 ongoing clinical trials across 31 countries. These numbers represent more than data — they represent progress, and lives. Discover how smart research is driving change.

We started a global trial, U-R-Immune Glioma, investigating whether Immune therapy can offer an alternative treatment for children and young adults with brain tumours. In collaboration with SickKids and CHEO in Canada.

We have uncovered alarming practices in private cancer clinics, where cancer patients are being charged tens of thousands of euros for unproven cancer treatments. We raised concerns about these dangerous practices to investigator journalists, to help protect cancer patients and and fight misinformation.

The Anticancer Fund now receives support from the National Lottery for My Cancer Navigator, our free information service. This partnership will allow us to help more cancer patients.

Happy to share the key findings from a survey we have done in partnership with KU Leuven and Optigage, highlighting the powerful impact of My Cancer Navigator, our personalized service designed to support cancer patients.